Clinical efficacy of adjuvant treatments for patients with resected biliary tract cancer: a systematic review and network meta-analysis

医学 荟萃分析 佐剂 内科学 辅助治疗 肿瘤科 放射治疗 放化疗 癌症 外科
作者
Ye Chen,Baoxia Zhang,Chang Xin Liu,Ye Cao,Cheng Lyu,Meng Qiu
出处
期刊:BMJ Open [BMJ]
卷期号:12 (4): e051421-e051421 被引量:9
标识
DOI:10.1136/bmjopen-2021-051421
摘要

OBJECTIVE: This study aimed to determine the benefits of adjuvant therapy in patients with resected biliary tract cancer (BTC) and identify the optimal adjuvant treatment scheme. DESIGN: Systematic review and network meta-analysis. DATA SOURCES: Studies comparing different adjuvant therapies in patients with BTC were searched in PubMed, Embase, CINAHL, Cochrane Central Register of Controlled Trials and ClinicalTrials.gov databases from inception to December 2021. Additionally, the references were manually searched for the related literature. MATERIALS AND METHODS: Eligible studies were identified, and data were extracted independently by two authors. A random-effects network meta-analysis was performed using R software. The pooled outcomes of overall survival (OS) and disease-free survival (DFS) were measured using the combined HRs with 95% CIs. RESULTS: Nineteen eligible studies reporting three types of adjuvant therapies were included in our network meta-analysis. Adjuvant radiotherapy (ART, HR 0.62; 95% CI 0.42 to 0.93), adjuvant chemoradiotherapy (ACRT; HR 0.71; 95% CI 0.54 to 0.83) and adjuvant chemotherapy (ACT; HR 0.84; 95% CI 0.68 to 0.98) were more effective in prolonging OS than that of observation, with no significant difference between the three adjuvant therapies. Moreover, the improvement in DFS was also found in ACRT and ACT compared with that of observation (HR 0.60; 95% CI 0.45 to 0.75; HR 0.82; 95% CI 0.68 to 0.97, respectively). Furthermore, ACRT obtained a slightly better DFS benefit compared with that of ACT (HR 0.73; 95% CI 0.53 to 0.95). CONCLUSIONS: Our primary results demonstrated that, compared with that of observation, ACRT and ACT after radical resection could provide better OS and DFS benefits in patients with BTC. However, ART only showed improvement in OS, but not in DFS. Due to the lack of head-to-head studies of ACT, ACRT and ART, the above results need to be further verified by prospective randomised controlled trials.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
顺利若蕊完成签到,获得积分10
1秒前
Goodnight发布了新的文献求助10
1秒前
1秒前
1秒前
风中书本发布了新的文献求助10
1秒前
shoot4af完成签到,获得积分10
1秒前
1秒前
GuoPLess发布了新的文献求助10
2秒前
2秒前
3秒前
高扬发布了新的文献求助10
3秒前
sunny发布了新的文献求助10
4秒前
4秒前
4秒前
Kelly发布了新的文献求助10
4秒前
4秒前
冷静的鸡完成签到,获得积分10
4秒前
华仔的应助被CJY采纳,获得10
5秒前
完美世界的应助被ldd采纳,获得10
5秒前
ding的应助被Moon采纳,获得10
5秒前
DW的应助被胡萝卜卜采纳,获得10
5秒前
Charming完成签到,获得积分10
5秒前
5秒前
5秒前
Wenlia发布了新的文献求助10
6秒前
领导范儿的应助被曲阿杰采纳,获得10
6秒前
6秒前
7秒前
chemistry完成签到,获得积分10
7秒前
zc发布了新的文献求助10
7秒前
Vanff发布了新的文献求助10
7秒前
无风完成签到 ,获得积分10
8秒前
8秒前
8秒前
Owen的应助被凛时雨采纳,获得10
8秒前
yongqi发布了新的文献求助10
8秒前
领导范儿的应助被赵小卷采纳,获得10
8秒前
gaga完成签到 ,获得积分10
8秒前
饺子发布了新的文献求助10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8162816
求助须知:如何正确求助?哪些是违规求助? 9557103
关于积分的说明 21738393
捐赠科研通 7753330
什么是DOI,文献DOI怎么找? 3427963
关于科研通互助平台的介绍 2552742
邀请新用户注册赠送积分活动 2472556